Skip to main content

Get Health Care
About
Giving
Find Faculty
Library
RUSH U Portal
I am a...
Select from the list below to customize your experience: Select a new category

I am a:

Education
Looking to take the next step in your career? RUSH University offers a wide range of education and training options, including nationally ranked academic programs.

Find a Program
- Colleges
- Quick Links
Admissions
Student Life
Experience what life is like at RUSH University, and discover what our supportive learning community has to offer.

Learn More About Student Life
- About the RUSH Experience
- Quick Links
Research
RUSH researchers are leading efforts to cure disease and promote health equity — in Chicago and around the world.

Learn More About Research
- About Our Research
- Quick Links

Get Health Care
About
Giving
Find Faculty
Library
RUSH U Portal
I am a...
Select from the list below to customize your experience: Select a new category

I am a:

Search RUSH University

Jeffrey R. Schneider, PhD

Breadcrumb

Home
Jeffrey R. Schneider, PhD

Home

Assistant Professor, Department of Microbial Pathogens and Immunity

Rush Medical College

Assistant Professor, Department of Microbial Pathogens and Immunity

Contact Information

Address: 1735 W. Harrison St., Suite 618 (Cohn Building)
Chicago, IL 60612
Phone:
(312) 942-6819
Email:
jeffrey_schneider@rush.edu

Links

Print this Page

Research Profile

Off

PhD, Molecular Pathogenesis and Molecular Medicine, University of Chicago
BS, Bioengineering, University of Illinois Urbana-Champaign
Jeffrey R. Schneider, PhD’s lab focuses on HIV antibody distribution. He has helped develop a platform to track intravenous injected fluorophore conjugated IgG in plasma, tissue, and weck-cel fluid. This methodology has led to a grant to study how the timing of antibody injection affects distal site accumulation of virus following challenge. Through a better understanding of how antibodies get to and fortify mucosal surfaces from incoming pathogens, this research has the potential to elucidate novel HIV prevention strategies with the ultimate goal of blocking initial HIV transmission. This work will help inform future passive immunization studies, such as the AMP (Antibody Mediated Prevention), trial which is currently underway and administering anti-HIV antibodies to at-risk individuals around the world. As the SARS-CoV-2 pandemic emerged, Schneider has adapted his work with HIV antibodies to better understand the neutralizing antibody response in COVID-19 patients.
- 2011 Biological Science Travel Award, University of Chicago Division of Biological Sciences
- 2014 Scholarship Recipient, HIV R4P Research for Prevention
- 2014 Session Chair and Scholarship Recipient, Keystone Symposia on HIV Vaccines
- 2014 HIV Research for Prevention Scholarship Recipient, Cape Town, South Africa
- 2015 CAVD Exchange Award, Bill and Melinda Gates Foundation
- 2016 Northwestern University Office of Post-doctoral Affairs Travel Award
- 2016 International AIDS Conference Scholarship Recipient, Durban, South Africa
- 2016 International AIDS Conference, Rapporteur-Basic Track, Durban, South Africa
- 2016 HIV Research for Prevention Scholarship Recipient, Chicago, U.S.
- NIH K01OD024882: "The role of steady state broadly neutralizing antibody tissue levels in preventing distal site SHIV replication"
- NIH R21MH125339: “Imaging the CNS SIV reservoir in a cART cessation model”
- Walder Foundation Grant, “Characterizing the neutralizing antibody response in SARS-CoV-2 infected individuals”
- Walder Foundation Grant, “Characterizing the long-term durability and composition of COVID-19 vaccine induced antibodies”
- Walder Foundation Grant, “B3: Boosters, Breakthroughs, and Biorepositories”

Main Section
- Colleges
- For Professionals
- For Students
- Resources
(312) 942-7100

RUSH University
600 S. Paulina St.
Chicago, Illinois 60612

Contact Us

Accessibility, Privacy & Harassment Policies

© 2024 RUSH University